Biotechnology Value Fund L P is a Hedge Fund in California, that has raised $1.51 bn from 27 investors, with a minimum investment of $25.00 mm, for a fund started in Sep 2008. Data from SEC filing on 29 Dec 2023.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
Industry (SIC)
Former names
Biotechnology Value Fund L P Et Al
SEC CIK
IRS number
363924731
AUM ?
$2.54 bn
Address
Biotechnology Value Fund L P
44 MONTGOMERY STREET
40TH FL
SAN FRANCISCO
CA 94104
44 MONTGOMERY STREET
40TH FL
SAN FRANCISCO
CA 94104
Phone
3125066500
Ownership
Fund structure | AUM | Fund type |
---|---|---|
BVF Partners L.P. | $4.92 bn | |
Biotechnology Value Fund II, L.P. | $1.99 bn | Hedge Fund |
Biotechnology Value Fund, LP | $2.54 bn | Hedge Fund |
Biotechnology Value Trading Fund Os LP | $278.74 mm | Hedge Fund |
Biotechnology Value Fund Os LP | ||
BVF Investments, LLC | $1.54 mm | Hedge Fund |
Latest filings (excl ownership)
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
29 Dec 23
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
30 Dec 22
D/A
Indefinite amount in investment fund, sold $1.11B, 26 investors
4 Jan 22
D/A
Indefinite amount in investment fund, sold $675.08M, 24 investors
7 Jan 21
D/A
Indefinite amount in investment fund, sold $413.83M, 19 investors
10 Jan 20
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
11 Jan 19
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
8 Dec 17
D/A
Indefinite amount in investment fund, sold $212.03M, 17 investors
21 Sep 16
D/A
Indefinite amount in investment fund, sold $64.76M, 13 investors
12 Nov 14
D/A
Indefinite amount in investment fund, sold $41.66M, 14 investors
8 Nov 13
Latest ownership filings
SC 13D/A
Inventiva S.A.
19 Jul 24
4
MARK N LAMPERT
28 Jun 24
4
MARK N LAMPERT
18 Jun 24
4
MARK N LAMPERT
10 Jun 24
SC 13G
Celcuity Inc.
10 Jun 24
SC 13G
Foghorn Therapeutics Inc.
30 May 24
SC 13G
PIERIS PHARMACEUTICALS, INC.
17 May 24
SC 13G
PIERIS PHARMACEUTICALS, INC.
17 May 24
4
MARK N LAMPERT
13 May 24
SC 13D/A
MoonLake Immunotherapeutics
5 Mar 24